1. Home
  2. Live Updates
  3. Longboard pharmaceuticals inc

Live Breaking News & Updates on Longboard pharmaceuticals inc

Stay informed with the latest breaking news from Longboard pharmaceuticals inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Longboard pharmaceuticals inc and stay connected to the pulse of your community

Longboard Pharmaceuticals' (LBPH) "Buy" Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Longboard Pharmaceuticals (NASDAQ:LBPH – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $60.00 price objective on the stock. LBPH has been the topic of a number of other reports. Guggenheim increased their price objective on […]

Arena-pharmaceuticals-inc , News-ratings-for-longboard-pharmaceuticals-daily , Vanguard-group-inc , Jpmorgan-chase-co , Nasdaq , Longboard-pharmaceuticals-company-profile , Longboard-pharmaceuticals-inc , Blackrock-inc , Polar-capital-holdings-plc , Cantor-fitzgerald , Securities-exchange-commission

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns "Overweight" Rating from Cantor Fitzgerald

Longboard Pharmaceuticals (NASDAQ:LBPH) Earns "Overweight" Rating from Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Insider-transactions-at-longboard-pharmaceuticals , Manufacturers-life-insurance-company , Arena-pharmaceuticals-inc , Institutional-trading-of-longboard-pharmaceuticals , Analyst-recommendations-for-longboard-pharmaceuticals , Longboard-pharmaceuticals-company-profile , Longboard-pharmaceuticals , Longboard-pharmaceuticals-trading-down , Nuveen-asset-management , Citigroup-inc , News-ratings-for-longboard-pharmaceuticals-daily

Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15

PACIFIC Study Phase 1b/2a clinical data to be featured in a podium presentation at an Emerging Science Session at the AAN Annual Meeting




Data will be featured in an encore presentation at the...

Spain , Denver , Colorado , United-states , Madrid , Australia , Randall-kaye , Encephalopathies-dees , Longboard-pharmaceuticals-inc , Exchange-commission , Nasdaq , Longboard-pharmaceuticals

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

Encephalopathies-dees , Longboard-pharmaceuticals-inc , Exchange-commission , Nasdaq , Compensation-committee , Nasdaq-listing-rule , Common-stock , Epileptic-encephalopathies , Private-securities-litigation-reform-act ,

Longboard Pharmaceuticals (NASDAQ:LBPH) Shares Gap Up to $20.11

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report) gapped up before the market opened on Wednesday . The stock had previously closed at $20.11, but opened at $20.80. Longboard Pharmaceuticals shares last traded at $20.52, with a volume of 36,001 shares changing hands. Analyst Upgrades and Downgrades LBPH has been the topic of several analyst […]

Nasdaq , Asset-management-inc , Longboard-pharmaceuticals-inc , Securities-exchange-commission , York-mellon-corp , Longboard-pharmaceuticals-stock , Cantor-fitzgerald , Longboard-pharmaceuticals-company-profile , Citigroup-inc , Blackrock-inc , News-ratings-for-longboard-pharmaceuticals-daily

Roberts Leads Longboard Through Clinical-Stage Growth - San Diego Business Journal

Roberts Leads Longboard Through Clinical-Stage Growth - San Diego Business Journal
sdbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sdbj.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , University-of-san-diego , Anjeanette-bowman , Alexis-williams , Brandi-roberts , Jennifer-patterson , University-of-arizona , Brandi-roberts-longboard-pharmaceuticals-inc-photo , Pharmaceuticals-as-audit-committee , Pfizer

Stocks Fluctuate Before Feb ISM Manufacturing Report

Detailed price information for Hong Kong Dollar/Australian Dollar (HKDAUD) from The Globe and Mail including charting and trades.

Macau , United-kingdom , Germany , Texas , United-states , Shanghai , China , Michigan , Japan , German , America , Las-vegas-sands

Longboard Pharmaceuticals (NASDAQ:LBPH) Trading Down 4.7%

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH – Get Free Report)’s share price traded down 4.7% during trading on Thursday . The stock traded as low as $22.76 and last traded at $22.81. 48,819 shares were traded during mid-day trading, a decline of 98% from the average session volume of 2,009,614 shares. The stock had previously closed at […]

United-states , California , American , Arena-pharmaceuticals-inc , Longboard-pharmaceuticals-company-profile , Cantor-fitzgerald , Bourgeon-capital-management , Securities-exchange-commission , News-ratings-for-longboard-pharmaceuticals-daily , Wells-fargo-company , Citigroup

Analysts Set Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) PT at $36.00

Analysts Set Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) PT at $36.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Northern-trust-corp , Longboard-pharmaceuticals , Longboard-pharmaceuticals-price-performance , Nuveen-asset-management , Citigroup-inc , Goldman-sachs-group-inc , Analyst-recommendations-for-longboard-pharmaceuticals , Longboard-pharmaceuticals-inc , Nasdaq , Arena-pharmaceuticals-inc , Institutional-investors-weigh-in-on-longboard-pharmaceuticals

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Average Recommendation of "Buy" by Brokerages

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) Given Average Recommendation of "Buy" by Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Nasdaq , Citigroup , News-ratings-for-longboard-pharmaceuticals-daily , Insider-activity-at-longboard-pharmaceuticals , Vanguard-group-inc , Barclays-plc , Longboard-pharmaceuticals-inc , Hedge-funds-weigh-in-on-longboard-pharmaceuticals , Longboard-pharmaceuticals-price-performance , Bridgeway-capital-management , Longboard-pharmaceuticals